You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
EXPANSION OF HUMAN UMBILICAL CORD BLOOD STEM CELLS
SBC: Aastrom Biosciences, Inc. Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
Choosing a Plan for Minority & Undeserved Workers
SBC: ABACUS HEALTH SOLUTIONS, LLC Topic: N/AN/A
SBIR Phase I 1994 Department of Health and Human Services -
RAPID DRUG ASSAY BY SURFACE ENHANCED RAMAN SPECTROSCOPY
SBC: ADVANCED FUEL RESEARCH, INC. Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
COMMUNICATION AID UTILIZING WORD-LEVEL DISAMBIGUATION
SBC: Aiki Corporation Topic: N/ADESCRIPTION: The investigators propose to demonstrate the benefits of this technology for AAC by integrating it into a communication aid developed by the Prentke Romich Company, and by field-testing it with an appropriate sample population. Results of this feasibility study will be used in Phase II to develop a complete AAC system based on this technology. The reduced number of keys makes it po ...
SBIR Phase I 1997 Department of Health and Human Services -
DEVELOPMENT OF NEW ANTI-FELINE LEUKEMIA VIRUS DRUGS
SBC: ALBUQUERQUE AVIAN EXOTIC Topic: N/AIN COLLABORATIVE STUDIES WITH THE UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE, WE HAVE OBTAINED PRELIMINARY DATA ON THE ANTIVIRAL PROPERTIES OF DERIVATIVES OF THE NATURAL PRODUCT GOSSYPOL. IN PARTICULAR, ONE DERIVATIVE NAMED GIL HAS SHOW PROMISING ACTIVITY IN THE TREATMENTOF DOMESTIC CATS INFECTED WITH FELINE LEUKEMIA VIRUS (FELV). ALSO NOTEWORTHY IS THE FACT THAT GIL SHOWS PROMISING IN VITRO ACTI ...
SBIR Phase I 1992 Department of Health and Human Services -
TRAINING SECONDARY PREVENTION OF FETAL ALCOHOL SYNDROME
SBC: Alcohol Self-control Program Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
Somatic Cell Gene Therapy for Hemophilia B
SBC: Alexion Pharmaceuticals, Inc. Topic: N/ABlood coagulation factor IX is absent or deficient in hemophilia B patients. Current therapy, thetransfusion of human whole blood components, is effective, but it is not prophylactic or free of risk.Our long term objective is the development of a somatic cell gene therapy for hemophilia B. Autologouscapillary endothelial cells from adipose tissue of a hemophilia B patient will be isolated, transdu ...
SBIR Phase I 1994 Department of Health and Human Services -
COMPLEMENT ACTIVATION AND MYOCARDIAL INFARCTION
SBC: Alexion Pharmaceuticals, Inc. Topic: N/ACoronary artery disease is associated with extensive morbidity and mortality as well as substantial financial cost. An estimated 11.2 million people in the USA have coronary artery disease that leads to approximately 1.5 million acute myocardial infarctions (AMI) annually. The mechanism by which tissue injury occurs after AMI has not been fully elucidated. However, both animal models and human stu ...
SBIR Phase I 1997 Department of Health and Human Services -
Complement Activation and the Platelet Storage Le
SBC: Alexion Pharmaceuticals, Inc. Topic: N/AN/A
SBIR Phase I 1994 Department of Health and Human Services -
AUTOMATION OF DRUG DISTRIBUTION IN FEDERAL HOSPITALS
SBC: American Biorobotics Inc. Topic: N/AN/A
SBIR Phase I 1992 Department of Health and Human Services